Mikó P, Schreiner M, Fehér J
Magyar Néphadsereg Egészségügyi Szolgálat Györ-Sopron Megyei Kórház Központi Laboratórium.
Orv Hetil. 1990 Mar 25;131(12):627-9.
The exocrine pancreatic function was examined in 20 patient without any detectable gastrointestinal disorder. We used 1 g 4(N-acetyl-L-thyrosil) aminobenzoic acid (ALTAB) an Lundh's test meal containing 25 g lactose, and the test was repeated with 3 g lactase (Galantase). The urine was collected for 6 hours to check PABA excretion in urine. Lactose intolerance was diagnosed in 10 patients on the basis of an increase of H2 in the breath at least 15 ppm after Lundh's test meal and/or diarrhoea after test in two hours if this diarrhoea could be prevented by giving Galantase orally. We measured PABA excretion in patients with and without lactose intolerance after Lundh's test meal: 17.8% (SD = 6.7) and 47% (SD = 13) respectively (p less than 0.001), and after Lundh's test meal with Galantase: 34.3% (SD = 12.7) and 43.6% (SD = 10.9) respectively. The increase after Galantase in the group with lactose intolerance was significant (p less than 0.01).
对20例无任何可检测到的胃肠道疾病的患者进行了外分泌胰腺功能检查。我们使用了1克4(N - 乙酰 - L - 酪氨酸)氨基苯甲酸(ALTAB)和含25克乳糖的伦德试验餐,并且在服用3克乳糖酶(加兰他酶)后重复该试验。收集尿液6小时以检查尿液中对氨基苯甲酸(PABA)的排泄情况。根据伦德试验餐后呼出气体中氢气增加至少15 ppm和/或试验后两小时内出现腹泻(如果口服加兰他酶可预防该腹泻),诊断出10例乳糖不耐受患者。我们测量了伦德试验餐后有和没有乳糖不耐受患者的PABA排泄情况:分别为17.8%(标准差 = 6.7)和47%(标准差 = 13)(p < 0.001),以及服用加兰他酶后的伦德试验餐后:分别为34.3%(标准差 = 12.7)和43.6%(标准差 = 10.9)。乳糖不耐受组服用加兰他酶后的增加具有显著性(p < 0.01)。